Does a prominent figure's late-stage diagnosis suggest standard prostate cancer screening guidelines for men over 70 need urgent reevaluation?

Question

Accepted Answer

No. A single high-profile late-stage diagnosis does not by itself justify an urgent rewrite of prostate cancer screening guidelines for men over 70. Current guidance already reflects a central medical trade-off: PSA screening can reduce metastatic disease and some prostate-cancer deaths, but it also causes false positives, overdiagnosis and unnecessary treatment, especially in older men. The U.S. Preventive Services Task Force recommends against routine screening at 70 and older, while other groups, including urology specialists, increasingly favor individualized decisions based on life expectancy, overall health, family history, ancestry and patient preference. Biden’s case does sharpen questions about whether some older men with substantial life expectancy may benefit from continued screening beyond 70. That is not a new idea. Several contemporary recommendations already allow screening after 70 when a man is healthy enough to live another 7 to 10 years and is willing to weigh the risks and benefits. Experts also note that aggressive cancers can sometimes arise or progress despite prior screening, and PSA is an imperfect test. What the case most clearly supports is not blanket screening for all men over 70, but better risk-based, shared decision-making. Men at higher risk — including those with a strong family history, certain genetic mutations or Black ancestry — may warrant earlier or longer screening discussions. It also underscores the value of newer follow-up tools su…

Biden Says Stage 4 Cancer Would Have Kept Him Out of 2024 Race

Sources

Sources

Biden Says Stage 4 Cancer Would Have Kept Him Out of 2024 Race

Summary

Sources

Insights

Related Stories

Sources

Related Stories